Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.
Scope of the Report:
This report focuses on the Organ Transplant Immunosuppressant Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Organ Transplant Immunosuppressant Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
F. Hoffmann-La Roche Ltd.
Sanofi
AbbVie, Inc.
Allergan plc.
Astellas Pharma, Inc.
Bristol-Myers Squibb Company
Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Janssen Pharmaceutical
Novartis AG
Pfizer, Inc.
Veloxis Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibodies
Antiproliferative Agents
Calcineurin Inhibitors
mTOR Inhibitors
Steroids
Market Segment by Applications, can be divided into
Bone Marrow Transplant
Heart Transplant
Kidney Transplant
Liver Transplant
Lung Transplant
There are 15 Chapters to deeply display the global Organ Transplant Immunosuppressant Drugs market.
Chapter 1, to describe Organ Transplant Immunosuppressant Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Organ Transplant Immunosuppressant Drugs, with sales, revenue, and price of Organ Transplant Immunosuppressant Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Organ Transplant Immunosuppressant Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Organ Transplant Immunosuppressant Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Organ Transplant Immunosuppressant Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
1.1 Organ Transplant Immunosuppressant Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Antibodies
1.2.2 Antiproliferative Agents
1.2.3 Calcineurin Inhibitors
1.2.4 mTOR Inhibitors
1.2.5 Steroids
1.3 Market Analysis by Applications
1.3.1 Bone Marrow Transplant
1.3.2 Heart Transplant
1.3.3 Kidney Transplant
1.3.4 Liver Transplant
1.3.5 Lung Transplant
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche Ltd.
2.1.1 Business Overview
2.1.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AbbVie, Inc.
2.3.1 Business Overview
2.3.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Allergan plc.
2.4.1 Business Overview
2.4.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Allergan plc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Astellas Pharma, Inc.
2.5.1 Business Overview
2.5.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb Company
2.6.1 Business Overview
2.6.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hoffmann-La Roche Ltd.
2.7.1 Business Overview
2.7.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 GlaxoSmithKline plc
2.8.1 Business Overview
2.8.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Janssen Pharmaceutical
2.9.1 Business Overview
2.9.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis AG
2.10.1 Business Overview
2.10.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer, Inc.
2.11.1 Business Overview
2.11.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Veloxis Pharmaceuticals
2.12.1 Business Overview
2.12.2 Organ Transplant Immunosuppressant Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Organ Transplant Immunosuppressant Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Organ Transplant Immunosuppressant Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Organ Transplant Immunosuppressant Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Organ Transplant Immunosuppressant Drugs Market Analysis by Regions
4.1 Global Organ Transplant Immunosuppressant Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Organ Transplant Immunosuppressant Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
4.5 South America Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
5 North America Organ Transplant Immunosuppressant Drugs by Countries
5.1 North America Organ Transplant Immunosuppressant Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
6 Europe Organ Transplant Immunosuppressant Drugs by Countries
6.1 Europe Organ Transplant Immunosuppressant Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
6.3 UK Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
6.4 France Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Organ Transplant Immunosuppressant Drugs by Countries
7.1 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
7.5 India Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
8 South America Organ Transplant Immunosuppressant Drugs by Countries
8.1 South America Organ Transplant Immunosuppressant Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Organ Transplant Immunosuppressant Drugs by Countries
9.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
10 Global Organ Transplant Immunosuppressant Drugs Market Segment by Type
10.1 Global Organ Transplant Immunosuppressant Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Type (2013-2018)
10.2 Antibodies Sales Growth and Price
10.2.1 Global Antibodies Sales Growth (2013-2018)
10.2.2 Global Antibodies Price (2013-2018)
10.3 Antiproliferative Agents Sales Growth and Price
10.3.1 Global Antiproliferative Agents Sales Growth (2013-2018)
10.3.2 Global Antiproliferative Agents Price (2013-2018)
10.4 Calcineurin Inhibitors Sales Growth and Price
10.4.1 Global Calcineurin Inhibitors Sales Growth (2013-2018)
10.4.2 Global Calcineurin Inhibitors Price (2013-2018)
10.5 mTOR Inhibitors Sales Growth and Price
10.5.1 Global mTOR Inhibitors Sales Growth (2013-2018)
10.5.2 Global mTOR Inhibitors Price (2013-2018)
10.6 Steroids Sales Growth and Price
10.6.1 Global Steroids Sales Growth (2013-2018)
10.6.2 Global Steroids Price (2013-2018)
11 Global Organ Transplant Immunosuppressant Drugs Market Segment by Application
11.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2013-2018)
11.2 Bone Marrow Transplant Sales Growth (2013-2018)
11.3 Heart Transplant Sales Growth (2013-2018)
11.4 Kidney Transplant Sales Growth (2013-2018)
11.5 Liver Transplant Sales Growth (2013-2018)
11.6 Lung Transplant Sales Growth (2013-2018)
12 Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
12.1 Global Organ Transplant Immunosuppressant Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Organ Transplant Immunosuppressant Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
12.2.2 Europe Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
12.2.4 South America Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
12.3 Organ Transplant Immunosuppressant Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Organ Transplant Immunosuppressant Drugs Market Share Forecast by Type (2018-2023)
12.4 Organ Transplant Immunosuppressant Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Organ Transplant Immunosuppressant Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Organ Transplant Immunosuppressant Drugs Picture
Table Product Specifications of Organ Transplant Immunosuppressant Drugs
Figure Global Sales Market Share of Organ Transplant Immunosuppressant Drugs by Types in 2017
Table Organ Transplant Immunosuppressant Drugs Types for Major Manufacturers
Figure Antibodies Picture
Figure Antiproliferative Agents Picture
Figure Calcineurin Inhibitors Picture
Figure mTOR Inhibitors Picture
Figure Steroids Picture
Figure Organ Transplant Immunosuppressant Drugs Sales Market Share by Applications in 2017
Figure Bone Marrow Transplant Picture
Figure Heart Transplant Picture
Figure Kidney Transplant Picture
Figure Liver Transplant Picture
Figure Lung Transplant Picture
Figure United States Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Organ Transplant Immunosuppressant Drugs Revenue (Value) and Growth Rate (2013-2023)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Type and Applications
Table F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Organ Transplant Immunosuppressant Drugs Type and Applications
Table Sanofi Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Type and Applications
Table AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan plc. Basic Information, Manufacturing Base and Competitors
Table Allergan plc. Organ Transplant Immunosuppressant Drugs Type and Applications
Table Allergan plc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Type and Applications
Table Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Type and Applications
Table Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Type and Applications
Table Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Type and Applications
Table GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Type and Applications
Table Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Organ Transplant Immunosuppressant Drugs Type and Applications
Table Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Type and Applications
Table Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Veloxis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Type and Applications
Table Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Organ Transplant Immunosuppressant Drugs Sales by Manufacturer (2016-2017)
Figure Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturer in 2016
Figure Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturer in 2017
Table Global Organ Transplant Immunosuppressant Drugs Revenue by Manufacturer (2016-2017)
Figure Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Organ Transplant Immunosuppressant Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Organ Transplant Immunosuppressant Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Global Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Sales by Regions (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Regions (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Revenue by Regions (2013-2018)
Figure Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Regions in 2013
Figure Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Regions in 2017
Figure North America Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Europe Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure South America Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure North America Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2013-2018)
Table North America Organ Transplant Immunosuppressant Drugs Sales by Countries (2013-2018)
Table North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries (2013-2018)
Figure North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries in 2013
Figure North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries in 2017
Table North America Organ Transplant Immunosuppressant Drugs Revenue by Countries (2013-2018)
Table North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries in 2013
Figure North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries in 2017
Figure United States Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Canada Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Europe Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2013-2018)
Table Europe Organ Transplant Immunosuppressant Drugs Sales by Countries (2013-2018)
Table Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries (2013-2018)
Table Europe Organ Transplant Immunosuppressant Drugs Revenue by Countries (2013-2018)
Figure Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries in 2016
Figure Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries in 2017
Figure Germany Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure UK Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure France Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Russia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Italy Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries 2017
Figure China Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Japan Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Korea Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure India Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure South America Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2013-2018)
Table South America Organ Transplant Immunosuppressant Drugs Sales by Countries (2013-2018)
Table South America Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries (2013-2018)
Figure South America Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries in 2017
Table South America Organ Transplant Immunosuppressant Drugs Revenue by Countries (2013-2018)
Table South America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries in 2017
Figure Brazil Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure UAE Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Sales by Type (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Sales Share by Type (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2013-2018)
Figure Global Antibodies Sales Growth (2013-2018)
Figure Global Antibodies Price (2013-2018)
Figure Global Antiproliferative Agents Sales Growth (2013-2018)
Figure Global Antiproliferative Agents Price (2013-2018)
Figure Global Calcineurin Inhibitors Sales Growth (2013-2018)
Figure Global Calcineurin Inhibitors Price (2013-2018)
Figure Global mTOR Inhibitors Sales Growth (2013-2018)
Figure Global mTOR Inhibitors Price (2013-2018)
Figure Global Steroids Sales Growth (2013-2018)
Figure Global Steroids Price (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Sales by Application (2013-2018)
Table Global Organ Transplant Immunosuppressant Drugs Sales Share by Application (2013-2018)
Figure Global Heart Transplant Sales Growth (2013-2018)
Figure Global Kidney Transplant Sales Growth (2013-2018)
Figure Global Liver Transplant Sales Growth (2013-2018)
Figure Global Lung Transplant Sales Growth (2013-2018)
Figure Global Organ Transplant Immunosuppressant Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Regions (2018-2023)
Table Global Organ Transplant Immunosuppressant Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
Figure Europe Sales Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
Figure South America Sales Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Organ Transplant Immunosuppressant Drugs Market Forecast (2018-2023)
Table Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2018-2023)
Table Global Organ Transplant Immunosuppressant Drugs Market Share Forecast by Type (2018-2023)
Table Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2018-2023)
Table Global Organ Transplant Immunosuppressant Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
